Data / Drug companies / Bel Star S a
Bel Star S a: 180 products in the FDA NDC directory, labeler code 14141
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bel Star S a (labeler code 14141) lists 180 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 180 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 23, 2026.
The request: Watch Bel Star S a (FDA labeler code 14141): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 14141
- Products in commercial distribution
- 180
- Packages
- 181
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 180
- Flagged as original packager
- 175 of 175 products that carry the flag
- Started marketing in the last 12 months
- 36
- Earliest marketing start
- December 21, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 180 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 180 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Octinoxate, zinc oxide | 141 | 9 |
| Aluminum sesquichlorohydrate | 14 | 15 |
| Octinoxate, titanium dioxide, zinc oxide | 12 | 7 |
| Titanium dioxide, zinc oxide | 5 | 255 |
| Avobenzone, octisalate, octocrylene | 4 | 54 |
| Zinc oxide, titantium dioxide, octinoxate | 1 | 1 |
| Avobenzone, octinoxate, octisalate, octocrylene | 1 | 15 |
| Homosalate, octocrylene, avobenzone | 1 | 2 |
| Avobenzone, homosalate, octocrylene | 1 | 21 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Emulsion | 129 | 71.7% |
| Powder | 23 | 12.8% |
| Stick | 18 | 10% |
| Liquid | 5 | 2.8% |
| Paste | 3 | 1.7% |
| Cream | 1 | 0.6% |
| Lotion | 1 | 0.6% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lbel solutions pro-hialuron base serum efecto relleno de arrugas fps 15 wrinkle filler effect serum foundation spf 15 capuccino 310-c | 14141-603 | Emulsion | Over the counter monograph drugs | September 23, 2026 |
| Lbel solutions pro-hialuron base serum efecto relleno de arrugas fps 15 wrinkle filler effect serum foundation spf 15 almendra 230-n | 14141-602 | Emulsion | Over the counter monograph drugs | September 23, 2026 |
| Lbel solutions pro-hialuron base serum efecto relleno de arrugas fps 15 wrinkle filler effect serum foundation spf 15 beige 220-c | 14141-601 | Emulsion | Over the counter monograph drugs | September 23, 2026 |
| Lbel solutions pro-hialuron base serum efecto relleno de arrugas fps 15 wrinkle filler effect serum foundation spf 15 latte 180-f | 14141-600 | Emulsion | Over the counter monograph drugs | September 23, 2026 |
| Lbel solutions pro-hialuron base serum efecto relleno de arrugas fps 15 wrinkle filler effect serum foundation spf 15 champagne 170-n | 14141-599 | Emulsion | Over the counter monograph drugs | September 23, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 420-c | 14141-598 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 310-c | 14141-597 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 270-c | 14141-596 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 220-c | 14141-595 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 200-c | 14141-594 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 180-f | 14141-593 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Esika colorfix polvos 32h polvo compacto facial de alta cobertura fps 15 110-c | 14141-592 | Powder | Over the counter monograph drugs | August 3, 2026 |
| Lbel solutions pro nude skin base serum tint cobertura antimanchas fps 15 anti dark spot coverage serum tint foundation spf 15 capuccino 310-c | 14141-591 | Emulsion | Over the counter monograph drugs | August 3, 2026 |
| Lbel solutions pro nude skin base serum tint cobertura antimanchas fps 15 anti dark spot coverage serum tint foundation spf 15 almendra 230-n | 14141-590 | Emulsion | Over the counter monograph drugs | August 3, 2026 |
| Lbel solutions pro nude skin base serum tint cobertura antimanchas fps 15 anti dark spot coverage serum tint foundation spf 15 beige 220-c | 14141-589 | Emulsion | Over the counter monograph drugs | August 3, 2026 |
| Lbel solutions pro nude skin base serum tint cobertura antimanchas fps 15 anti dark spot coverage serum tint foundation spf 15 latte 180-f | 14141-588 | Emulsion | Over the counter monograph drugs | August 3, 2026 |
| Lbel solutions pro nude skin base serum tint cobertura antimanchas fps 15 anti dark spot coverage serum tint foundation spf 15 champagne 170-n | 14141-587 | Emulsion | Over the counter monograph drugs | August 3, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 mocha 420c | 14141-586 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 cacao 350n | 14141-585 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 capuccino 310c | 14141-584 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 avellana 270c | 14141-583 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 almendra 230n | 14141-582 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 beige 220c | 14141-481 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 caramel 210f | 14141-480 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
| Lbel forever matte shine control and 90h hydration foundation spf 15 latte 180f | 14141-479 | Emulsion | Over the counter monograph drugs | May 13, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.